Evolution of Peptide Drug Biopharmaceutics

被引:1
|
作者
Ivanov, V. T. [1 ]
Deigin, V. I. [1 ]
机构
[1] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia
关键词
peptide synthesis; biological activity; cyclopeptides; peptidomimetics; ORALLY-ACTIVE PEPTIDOMIMETICS; THERAPEUTIC PEPTIDES; FUTURE; PHARMACOKINETICS; DISCOVERY; PERMEABILITY; PLATFORM; PROTEIN;
D O I
10.1134/S1068162023030123
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
-Peptides are low-molecular-weight substances involved in numerous physiological processes, such as growth and development of the organism, stress, regulation of the emotional state, sexual behavior, and immune responses. Most peptides act as ligands for proteins, the interaction with which leads to highly selective effects. Such properties, as well as a low toxicity, allow us to consider peptides as potential effective drugs. The preparation of peptide drugs became possible at the beginning of the 20th century after the development of a method of their selective synthesis. Despite the success of the synthesis of the first peptide drugs, many issues associated with an increase in the stability, bioavailability, half-life, and the ability to move through the cell membranes remain unresolved. The review considers the historical path of development of the synthesis and production of peptides, and discusses modern approaches to the creation of peptide drugs and their application in biopharmaceutics, including in the development of original peptide drugs in Russia.
引用
收藏
页码:422 / 434
页数:13
相关论文
共 50 条
  • [31] DRUG SOLUBILITY IN THE CONTEXT OF AN INHALATION-BASED BIOPHARMACEUTICS CLASSIFICATION SYSTEM (IBCS)
    Floroiu, Andreea
    Loretz, Brigitta
    Kraemer, Johannes
    Lehr, Claus-Michael
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2023, 36 (06) : A10 - A10
  • [32] Revamping Biopharmaceutics-Pharmacokinetics with Scientific and Regulatory Implications for Oral Drug Absorption
    Nikolaos Alimpertis
    Athanasios A. Tsekouras
    Panos Macheras
    Pharmaceutical Research, 2023, 40 : 2167 - 2175
  • [33] Computational models to assign biopharmaceutics drug disposition classification from molecular structure
    Khandelwal, Akash
    Bahadduri, Praveen M.
    Chang, Cheng
    Polli, James E.
    Swaan, Peter W.
    Ekins, Sean
    PHARMACEUTICAL RESEARCH, 2007, 24 (12) : 2249 - 2262
  • [34] iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products
    Hastedt, Jayne E.
    Backman, Per
    Cabal, Antonio
    Clark, Andy
    Ehrhardt, Carsten
    Forbes, Ben
    Hickey, Anthony J.
    Hochhaus, Guenther
    Jiang, Wenlei
    Kassinos, Stavros
    Kuehl, Philip J.
    Prime, David
    Son, Yoen-Ju
    Teague, Simon
    Tehler, Ulrika
    Wylie, Jennifer
    MOLECULAR PHARMACEUTICS, 2023, 21 (01) : 164 - 172
  • [35] Computational Models to Assign Biopharmaceutics Drug Disposition Classification from Molecular Structure
    Akash Khandelwal
    Praveen M. Bahadduri
    Cheng Chang
    James E. Polli
    Peter W. Swaan
    Sean Ekins
    Pharmaceutical Research, 2007, 24 : 2249 - 2262
  • [36] Intrinsic Dissolution as a Tool for Evaluating Drug Solubility in Accordance with the Biopharmaceutics Classification System
    Issa, Michele G.
    Ferraz, Humberto G.
    DISSOLUTION TECHNOLOGIES, 2011, 18 (03): : 6 - 13
  • [37] TASKS OF BIOPHARMACEUTICS
    FURST, W
    PHARMAZIE, 1970, 25 (01): : 70 - &
  • [38] Revamping Biopharmaceutics-Pharmacokinetics with Scientific and Regulatory Implications for Oral Drug Absorption
    Alimpertis, Nikolaos
    Tsekouras, Athanasios A.
    Macheras, Panos
    PHARMACEUTICAL RESEARCH, 2023, 40 (09) : 2167 - 2175
  • [39] Feasibility of Biowaiver Extension to Biopharmaceutics Classification System Class III Drug ProductsCimetidine
    Ekarat Jantratid
    Sompol Prakongpan
    Gordon L. Amidon
    Jennifer B. Dressman
    Clinical Pharmacokinetics, 2006, 45 : 385 - 399
  • [40] BIOPHARMACEUTICS AND DRUG-INTERACTION, 3RD EDITION, CADWALLADER,DE
    ZIMMERMAN, CL
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 1984, 48 (02) : 226 - 226